Gil Blum
Stock Analyst at Needham
(3.71)
# 778
Out of 5,113 analysts
427
Total ratings
38.77%
Success rate
11.29%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Gil Blum
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SLDB Solid Biosciences | Reiterates: Buy | $16 | $6.45 | +148.06% | 2 | Jan 14, 2026 | |
| MREO Mereo BioPharma Group | Maintains: Buy | $5 → $3 | $0.49 | +509.63% | 21 | Jan 13, 2026 | |
| AUTL Autolus Therapeutics | Maintains: Buy | $11 → $10 | $1.39 | +619.42% | 34 | Jan 12, 2026 | |
| CRSP CRISPR Therapeutics AG | Reiterates: Buy | $80 | $54.65 | +46.39% | 27 | Dec 23, 2025 | |
| IMCR Immunocore Holdings | Reiterates: Buy | $71 | $35.08 | +102.39% | 14 | Apr 10, 2025 | |
| GERN Geron | Reiterates: Buy | $5 | $1.37 | +264.96% | 23 | May 2, 2024 | |
| RNAC Cartesian Therapeutics | Maintains: Buy | $40 → $42 | $7.61 | +451.91% | 16 | Jan 9, 2026 | |
| FOLD Amicus Therapeutics | Downgrades: Hold | n/a | $14.29 | - | 8 | Dec 19, 2025 | |
| ABSI Absci | Reiterates: Buy | $7 | $2.89 | +142.21% | 7 | Dec 12, 2025 | |
| NRIX Nurix Therapeutics | Reiterates: Buy | $26 | $18.75 | +38.67% | 28 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $105 | $68.55 | +53.17% | 24 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Suspends: Buy | $15 | $5.68 | +164.08% | 19 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $6 | $1.13 | +430.97% | 8 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $1.23 | - | 9 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $114.01 | -38.60% | 21 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $4.72 | +111.86% | 31 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $4.68 | +284.62% | 7 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $4.59 | +74.29% | 25 | Sep 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $2.46 | +306.50% | 18 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Underperform | n/a | $22.80 | - | 38 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | n/a | $3.63 | - | 22 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $4.08 | - | 16 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $48 | $12.21 | +293.12% | 9 | Aug 2, 2024 |
Solid Biosciences
Jan 14, 2026
Reiterates: Buy
Price Target: $16
Current: $6.45
Upside: +148.06%
Mereo BioPharma Group
Jan 13, 2026
Maintains: Buy
Price Target: $5 → $3
Current: $0.49
Upside: +509.63%
Autolus Therapeutics
Jan 12, 2026
Maintains: Buy
Price Target: $11 → $10
Current: $1.39
Upside: +619.42%
CRISPR Therapeutics AG
Dec 23, 2025
Reiterates: Buy
Price Target: $80
Current: $54.65
Upside: +46.39%
Immunocore Holdings
Apr 10, 2025
Reiterates: Buy
Price Target: $71
Current: $35.08
Upside: +102.39%
Geron
May 2, 2024
Reiterates: Buy
Price Target: $5
Current: $1.37
Upside: +264.96%
Cartesian Therapeutics
Jan 9, 2026
Maintains: Buy
Price Target: $40 → $42
Current: $7.61
Upside: +451.91%
Amicus Therapeutics
Dec 19, 2025
Downgrades: Hold
Price Target: n/a
Current: $14.29
Upside: -
Absci
Dec 12, 2025
Reiterates: Buy
Price Target: $7
Current: $2.89
Upside: +142.21%
Nurix Therapeutics
Dec 8, 2025
Reiterates: Buy
Price Target: $26
Current: $18.75
Upside: +38.67%
Dec 8, 2025
Reiterates: Buy
Price Target: $105
Current: $68.55
Upside: +53.17%
Nov 7, 2025
Suspends: Buy
Price Target: $15
Current: $5.68
Upside: +164.08%
Nov 4, 2025
Maintains: Buy
Price Target: $9 → $6
Current: $1.13
Upside: +430.97%
Oct 27, 2025
Reiterates: Hold
Price Target: n/a
Current: $1.23
Upside: -
Oct 20, 2025
Reiterates: Buy
Price Target: $70
Current: $114.01
Upside: -38.60%
Oct 17, 2025
Reiterates: Buy
Price Target: $10
Current: $4.72
Upside: +111.86%
Oct 17, 2025
Reiterates: Buy
Price Target: $18
Current: $4.68
Upside: +284.62%
Sep 11, 2025
Reiterates: Buy
Price Target: $8
Current: $4.59
Upside: +74.29%
Aug 13, 2025
Reiterates: Buy
Price Target: $10
Current: $2.46
Upside: +306.50%
Jul 29, 2025
Reiterates: Underperform
Price Target: n/a
Current: $22.80
Upside: -
Jul 24, 2025
Maintains: Hold
Price Target: n/a
Current: $3.63
Upside: -
Mar 27, 2025
Reiterates: Hold
Price Target: n/a
Current: $4.08
Upside: -
Aug 2, 2024
Reiterates: Buy
Price Target: $48
Current: $12.21
Upside: +293.12%